Covered recipient · General Payments record
CHRISTOPHER S NICKISON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,014.78
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $390.83 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $95.53 | 6 |
| ABBVIE INC. | $83.28 | 4 |
| Novo Nordisk AS | $49.36 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $25.99 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.45 | 1 |
| DEXCOM, INC. | $20.40 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.24 | 1 |
| Astellas Pharma US Inc | $16.94 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.09 | 1 |
| Lilly USA, LLC | $14.67 | 1 |
| Abbott Laboratories | $14.19 | 1 |
| Acerta Pharma LLC | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.19 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125359473 | CMS |
| ABBVIE INC. | $18.25 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124967 | CMS |
| ABBVIE INC. | $16.44 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124969 | CMS |
| ABBVIE INC. | $26.53 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124971 | CMS |
| ABBVIE INC. | $22.06 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105124973 | CMS |
| Astellas Pharma US Inc | $16.94 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139300028 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.69 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104319444 | CMS |
| Boston Scientific Corporation | $25.99 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092489550 | CMS |
| Dexcom, Inc. | $20.40 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292381 | CMS |
| Lilly USA, LLC | $14.67 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136098268 | CMS |
| Novo Nordisk Inc | $18.60 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097583785 | CMS |
| Novo Nordisk Inc | $16.48 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097496119 | CMS |
| Novo Nordisk Inc | $14.28 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097809923 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.24 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118951472 | CMS |
| PFIZER INC. | $17.71 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132030819 | CMS |
| PFIZER INC. | $14.35 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132030411 | CMS |
| PFIZER INC. | $17.72 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131653220 | CMS |
| PFIZER INC. | $16.11 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131741360 | CMS |
| PFIZER INC. | $15.29 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131751108 | CMS |
| PFIZER INC. | $14.35 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131971723 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.09 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151102791 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.45 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144590580 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.